Medtronics announces strategic investments in Pi-Cardia to accelerate innovation for complex TAVR

We are pleased to share that our portfolio company Pi-Cardia has announced a strategic investment from Medtronic, aimed at accelerating innovation for complex TAVR procedures and expanding access to its groundbreaking ShortCut™ technology.

We are proud to have believed in the technology since its first steps and to have supported it throughout an entire decade. This milestone highlights the clinical value of Pi-Cardia’s pioneering approach to leaflet modification and represents an important validation of the company’s vision to address unmet needs in structural heart disease.

Congratulations to Erez Golan, Eyal Kolka and the entire Pi-Cardia team for this remarkable achievement and for the impact they continue to make in cardiovascular care.

Read more: https://lnkd.in/eN5jZhaY